BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anderson R, Nel JG, Feldman C. Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia. Int J Mol Sci 2018;19:E1147. [PMID: 29641429 DOI: 10.3390/ijms19041147] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Principi N, Esposito S. Pneumococcal Disease Prevention: Are We on the Right Track? Vaccines (Basel) 2021;9:305. [PMID: 33804822 DOI: 10.3390/vaccines9040305] [Reference Citation Analysis]
2 Feldman C. Cardiac complications in community-acquired pneumonia and COVID-19. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235421 DOI: 10.7196/AJTCCM.2020.v26i2.077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Lv Q, Zhang P, Quan P, Cui M, Liu T, Yin Y, Chi G. Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection. Microb Pathog 2020;140:103934. [PMID: 31862394 DOI: 10.1016/j.micpath.2019.103934] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Feldman C, Anderson R. Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia. Front Immunol 2020;11:577303. [PMID: 33042161 DOI: 10.3389/fimmu.2020.577303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Feng S, Xiong C, Wang G, Wang S, Jin G, Gu G. Exploration of Recombinant Fusion Proteins YAPO and YAPL as Carrier Proteins for Glycoconjugate Vaccine Design against Streptococcus pneumoniae Infection. ACS Infect Dis 2020;6:2181-91. [PMID: 32687317 DOI: 10.1021/acsinfecdis.0c00260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Petukhova ES, Vorobyev DS, Sidorov AV, Semenova IB, Volokh YV, Leonova AY, Sidorova AV, Mikhailova NA. Immunization with Recombinant Pneumolysin Induces the Production of Antibodies and Protects Mice in a Model of Systemic Infection Caused by Streptococcus pneumoniae. Bull Exp Biol Med 2020;168:485-7. [PMID: 32146631 DOI: 10.1007/s10517-020-04736-6] [Reference Citation Analysis]
7 Salvador M, Marqués-Fernández JL, Bunge A, Martínez-García JC, Turcu R, Peddis D, García-Suárez MDM, Cima-Cabal MD, Rivas M. Magnetic Nanoclusters Increase the Sensitivity of Lateral Flow Immunoassays for Protein Detection: Application to Pneumolysin as a Biomarker for Streptococcus pneumoniae. Nanomaterials (Basel) 2022;12:2044. [PMID: 35745381 DOI: 10.3390/nano12122044] [Reference Citation Analysis]
8 Putot A, Bouhey E, Tetu J, Barben J, Timsit E, Putot S, Ray P, Manckoundia P. Troponin Elevation in Older Patients with Acute Pneumonia: Frequency and Prognostic Value. J Clin Med 2020;9:E3623. [PMID: 33182841 DOI: 10.3390/jcm9113623] [Reference Citation Analysis]
9 Africano HF, Serrano-Mayorga CC, Ramirez-Valbuena PC, Bustos IG, Bastidas A, Vargas HA, Gómez S, Rodriguez A, Orihuela CJ, Reyes LF. Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent. Clin Infect Dis 2021;72:e711-9. [PMID: 32964223 DOI: 10.1093/cid/ciaa1427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Feldman C, Normark S, Henriques‐normark B, Anderson R. Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community‐acquired pneumonia. J Intern Med 2019;285:635-52. [DOI: 10.1111/joim.12875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
11 Feldman C, Anderson R. Pneumococcal virulence factors in community-acquired pneumonia. Current Opinion in Pulmonary Medicine 2020;26:222-31. [DOI: 10.1097/mcp.0000000000000674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kucinskaite-Kodze I, Simanavicius M, Dapkunas J, Pleckaityte M, Zvirbliene A. Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity. Biomolecules 2020;10:E1009. [PMID: 32650398 DOI: 10.3390/biom10071009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Luck JN, Tettelin H, Orihuela CJ. Sugar-Coated Killer: Serotype 3 Pneumococcal Disease. Front Cell Infect Microbiol 2020;10:613287. [PMID: 33425786 DOI: 10.3389/fcimb.2020.613287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
14 Letsiou E, Teixeira Alves LG, Felten M, Mitchell TJ, Müller-Redetzky HC, Dudek SM, Witzenrath M. Neutrophil-Derived Extracellular Vesicles Activate Platelets after Pneumolysin Exposure. Cells 2021;10:3581. [PMID: 34944089 DOI: 10.3390/cells10123581] [Reference Citation Analysis]
15 Froneman C, Kelleher P, José RJ. Pneumococcal Vaccination in Immunocompromised Hosts: An Update. Vaccines (Basel) 2021;9:536. [PMID: 34063785 DOI: 10.3390/vaccines9060536] [Reference Citation Analysis]
16 Ruiz LA, Serrano L, España PP, Martinez-indart L, Gómez A, Uranga A, Castro S, Artaraz A, Zalacain R. Factors influencing long-term survival after hospitalization with pneumococcal pneumonia. Journal of Infection 2019;79:542-9. [DOI: 10.1016/j.jinf.2019.10.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 He Y, Zhang J, Shen G, Liu L, Zhao Q, Lu X, Yang H, Hong D. Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: a systematic review and meta-analysis. BMC Pharmacol Toxicol 2019;20:62. [PMID: 31665091 DOI: 10.1186/s40360-019-0339-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Pereira JM, Xu S, Leong JM, Sousa S. The Yin and Yang of Pneumolysin During Pneumococcal Infection. Front Immunol 2022;13:878244. [DOI: 10.3389/fimmu.2022.878244] [Reference Citation Analysis]
19 Kammann T, Hoff J, Yildirim I, Shkodra B, Müller T, Weber C, Gräler MH, Maus UA, Paton JC, Singer M, Traeger A, Schubert US, Bauer M, Press AT. Intracellularly Released Cholesterol from Polymer-Based Delivery Systems Alters Cellular Responses to Pneumolysin and Promotes Cell Survival. Metabolites 2021;11:821. [PMID: 34940579 DOI: 10.3390/metabo11120821] [Reference Citation Analysis]
20 Rombauts A, Abelenda-Alonso G, Càmara J, Lorenzo-Esteller L, González-Díaz A, Sastre-Escolà E, Gudiol C, Dorca J, Tebé C, Pallarès N, Ardanuy C, Carratalà J. Host- and Pathogen-Related Factors for Acute Cardiac Events in Pneumococcal Pneumonia. Open Forum Infect Dis 2020;7:ofaa522. [PMID: 33335932 DOI: 10.1093/ofid/ofaa522] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]